# MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors

> **NCT07004647** · NA · RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Peritoneal Tumor

## Interventions

- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT07004647
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-15
- **Primary completion:** 2028-10-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07004647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07004647, "MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07004647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*